The Shift to Toxicological-Related Deaths Over Natural During the COVID-19 Pandemic—An Ontario, Canada, Experience

Author:

French Karissa,Jhirad Reuven,Herath JayanthaORCID

Abstract

Study Design: Retrospective review of deaths in Ontario where there was Coroner’s investigation and a postmortem examination between 2018 and 2021 to compare year by year changes before and during the COVID-19 pandemic. Objective: To establish the changes in patterns of toxicological deaths over the pandemic. Methods: Using the database of the Office of the Chief Coroner for Ontario to determine the numbers of postmortem examinations for the province of Ontario as well as the primary cause and manner of death. Those with a toxicological primary cause of death were isolated from 2003 to the first half of 2022 and divided by year. For those between the years 2018 and 2021 deaths were divided by manner of death. Further all deaths with either a toxicological primary cause of death or unfinalized investigations which were highly suspicious for a toxicological cause based on circumstance with a positive toxicology were isolated. From these the data on demographics and substances detected were compiled by year for comparison. Results: Comparing two years prior to the COVID-19 pandemic to the following two years there was an increase in total case load of 22%. Comparing the year before the pandemic to the first year of the pandemic deaths from natural causes fell from 52% to 47% of total cases, while drug-related cases increased from 24% to 36%. Fentanyl remained as the most prevalent detected substance in toxicological deaths. Combined opioid toxicity with stimulants increased, as well as the detection of nonpharmaceutical benzodiazepines. Deaths in men increased to comprise 3 in 4 drug-related deaths with the 30 to 39 years age-group remaining the most impacted. Conclusions: There was an increase in numbers and relative proportions of cases attributed to drug-related deaths which remained high over the two years of the pandemic.

Publisher

SAGE Publications

Reference7 articles.

1. Government of Ontario. Office of the Premier. Ontario enacts declaration of emergency to protect the public: significantly enhanced measures will help contain spread of COVID-19 [Internet]. Queen’s Printer for Ontario; 2020. Accessed October 15, 2020. https://news.ontario.ca/en/release/56356/ontario-enacts-declaration-of-emergency-to-protect-the-public

2. Evidence synthesis - The opioid crisis in Canada: a national perspective

3. Ontario Drug Policy Research Network; Office of the Chief Coroner for Ontario/Ontario Forensic Pathology Service; Ontario Agency for Health Protection and Promotion (Public Health Ontario) Centre on Drug Policy Evaluation. Preliminary patterns in circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic. Ontario Drug Policy Research Network; 2020.

4. National Center for Biotechnology Information. PubChem compound summary for CID 3307, etizolam. 2023. Accessed March 3, 2023. https://pubchem.ncbi.nlm.nih.gov/compound/Etizolam

5. National Center for Biotechnology Information. PubChem compound summary for CID 10359044, flualprazolam. 2023. Accessed March 3, 2023. https://pubchem.ncbi.nlm.nih.gov/compound/Flualprazolam

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3